The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 353:2513-2515 December 8, 2005 Number 23
NextNext

Perioperative Beta-Blocker Therapy and Mortality

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Lindenauer, P. K.
-PubMed Citation
To the Editor: The large observational study by Lindenauer et al. (July 28 issue)1 seems to confirm that the administration of beta-blockers improves the postoperative outcome of very high-risk patients undergoing major surgery. Owing to the nonrandomized design of the study, the authors cannot exclude the possibility that other cardioprotective strategies — including prolonged monitoring, aggressive pain control and rehabilitation, intensive insulin therapy, and continuation of lipid-lowering agents — could have been used more frequently or adequately for the patients at highest risk.2,3

On the other hand, the potential harmful effects of beta-blockers raise several questions, including why almost 20 . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.